Adamis Pharmaceuticals (NASDAQ: ADMP) stock is back down 40% this morning, After yesterday’s up to 480% rise in ADMP stock that is, although the close was at 170% up. The net of this - at least so far ...

It’s an unusual day for Adamis Pharmaceuticals (NASDAQ:ADMP) stock traders, to say the least. That’s because the company recently announced its intent to acquire DMK Pharmaceuticals. Adamis’ ...

Adamis Pharmaceuticals (NASDAQ:ADMP) is a mover and shaker out on the Street today, with investors sparking the stock on an almost 45% upturn. Why the excitement? The drug maker announced a strategic ...

The market expects Adamis Pharmaceuticals (ADMP) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended September 2018. This widely-known ...

Adamis Pharmaceutical (NASDAQ: ADMP) stock has not done well for investors these past few years. 89% value destruction in the past 12 months, 99% in the past 5 years, 26% down just on the one day, ...

Hedge Funds and other institutional investors have just completed filing their 13Fs with the Securities and Exchange Commission, revealing their equity portfolios as of the end of September. At ...

We are still in an overall bull market and many stocks that smart money investors were piling into surged through the end of November. Among them, Facebook and Microsoft ranked among the top 3 picks ...

On Monday, shares of Adamis Pharmaceuticals Corp. ADMP are crashing, down over 50% in morning trading after news broke that the Food and Drug Administration (FDA) sent the company a Complete Response ...

Continuing the "DAM is morphing" thread, I am going to describe the ADMP variation -- or Application & Database Monitoring & Protection. As the name implies, ADMP couples application monitoring with ...